Authors
Latest:
Fighting Free Radicals: Do You Need Antioxidants?Patients may have questions about taking antioxidants.
Latest:
Cost-Effectiveness of Rasagiline Compared With First-Line Early Parkinson Disease TherapiesExamination of the cost-effectiveness of rasagiline versus other approved first-line Parkinson disease therapies indicated that rasagiline was either cost saving or cost-effective in all cases.
Latest:
Challenges of Channel Management for Specialty: Medical Benefit or Pharmacy BenefitRegardless of the channel through which a specialty medication is billed and filled, management strategies will be an essential cornerstone to controlling costs.
Latest:
Do Statins Interfere With Clopidogrel During Platelet Therapy?Despite data that might suggest a drug interaction, clinical significance is the deciding factor when considering therapeutic benefit over risk.
Latest:
Health Information Technology: Facilitating an Evolution in Health CareThe use of health information technology empowers pharmacists to provide enhanced care by harnessing a wealth of actionable information.
Latest:
A Closer Look at New FDA Actions: Amgen's ProliaAmgen Inc's new monoclonal antibody Prolia (denosumab) is the first "biologic therapy" approved by the FDA for the treatment of osteoporosis in menopausal women.
Latest:
An Intermittent Reinforcement Platform to Increase Adherence to MedicationsAn automated reinforcement platform was shown to increase statin adherence by 34.6%.
Latest:
Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting StrategyThis prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.
Latest:
Introduction to the Hospital-Acquired Condition Reduction Program for PharmacyThis manuscript addresses pharmacist understanding of and/or involvement with the Hospital-Acquired Condition Reduction Program (HACRP) at their institutions.
Latest:
Medication Nonadherence in the Latino Population: A Challenge and an Opportunity for Specialized ServicesAs US demographics steadily shift towards minorities and immigrants from diverse backgrounds, health care workers must be prepared to face new cultural challenges that may impact health behaviors, including medication adherence in these populations.
Latest:
US Primary Care Providers' Use of Over-the-Counter Medications for Gastroesophageal Reflux Disease and Chronic ConstipationThe perception and utilization of OTC medications among primary care providers for gastroesophageal reflux disease and chronic constipation shows a need for improved patient education on these medications.
Latest:
Three Challenges in Medication Adherence That Can Be Overcome by PharmacistsMedication nonadherence results in greater health care spending and poorer patient health outcomes.
Latest:
University Partnerships: Empowering the Next Generation of PharmacistsCorporate and academic partnerships help prepare new graduates for the world of specialty pharmacy.
Latest:
Combining a Passion for Making a Difference With EntrepreneurshipDirections in Oncology Pharmacy® talks to Gordon Vanscoy, PharmD, MBA, CACP, recently named a national Entrepreneur of the Year for 2020 by Ernst & Young.
Latest:
Penicillin Allergies and Cross-Reactivity With Other Beta-LactamsPatient-reported allergy to penicillin antibiotics is a common scenario during health care encounters, with an estimated population prevalence of roughly 8% to 12%.
Latest:
Pharmacists Can Play Key Role in Drug RepurposingPharmacists should be aware of what drug repurposing is and how it occurs as due to the vast amount of opportunities that exist.
Latest:
Economic Burden of Atrial Fibrillation: Implications for InterventionBecause the increasing prevalence of atrial fibrillation imposes significant financial and clinical burdens, efficient healthcare delivery is required to improve outcomes and reduce associated costs.
Latest:
Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid ArthritisFor patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.
Latest:
Economic Model of Granulocyte Colony-Stimulating Factors for Patients Receiving ChemotherapyFor US payers, pegfilgrastim is a less-expensive choice than daily filgrastim for reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy.
